Exo Biologics
Exo Biologics
MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom
BIOT
📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬
Boosting Lyophilization Productivity by 300: A Game-Changing Digital Twin Approach
BIOT
📰 Researchers at Clausthal University of Technology in Germany have found that using a digital twin approach during the freeze-drying process for biologics can increase productivity by up to 300 🚀💰. This approach also reduces costs by 74 💵 and lowers the global warming potential by 64 🌍. Lyophilization DigitalTwin
Revolutionizing Therapy Development with ExoXpert: Harnessing the Power of Exosomes
BIOT
🌟 Introducing ExoXpert: A game-changing contract development and manufacturing organization for exosome-based therapies! 🚀 ExosomeTherapies CuttingEdgeTech
